Squid Muscle Peptides — Hermetica Encyclopedia
Extract · Marine-Derived

Squid Muscle Peptides

Preliminary EvidenceCompound

Hermetica Superfood Encyclopedia

The Short Answer

Squid muscle peptides are low molecular weight hydrolysates (900–5000 Da) enriched in hydrophobic amino acids that scavenge free radicals—including carbon-centered, hydroxyl, and superoxide species—and inhibit angiotensin-converting enzyme (ACE) through hydrophobic C-terminal interactions. In vitro studies demonstrate radical scavenging IC50 values of 304.67–396.04 μM (carbon-centered), 428.54–497.32 μM (hydroxyl), and 573.83–669.34 μM (superoxide), alongside significant cytoprotective enhancement of embryonic lung fibroblast viability at 50 μg/ml (P<0.05).

PubMed Studies
7
Validated Benefits
Synergy Pairings
At a Glance
CategoryExtract
GroupMarine-Derived
Evidence LevelPreliminary
Primary Keywordsquid muscle peptides benefits
Peptides from Squid close-up macro showing natural texture and detail — rich in antioxidant, muscle, weight
Squid Muscle Peptides — botanical close-up

Health Benefits

**Antioxidant Activity**
Hydrophobic peptides from squid muscle act as chain-breaking antioxidants, inhibiting radical-mediated peroxidation of linoleic acid at activity levels comparable to the synthetic antioxidant butylated hydroxytoluene (BHT), via electron spin trapping of multiple radical species.
**ACE Inhibition and Antihypertensive Potential**
Identified peptides such as Asn-Ala-Asp-Phe-Gly-Leu-Asn-Gly-Leu-Glu-Gly-Leu-Ala (1307 Da) interact with angiotensin-converting enzyme active sites through hydrophobic C-terminal amino acids, potentially reducing vasoconstriction—though this effect has only been demonstrated in vitro.
**Cytoprotection of Fibroblasts**
At a concentration of 50 μg/ml, squid muscle peptides statistically significantly enhanced the viability of cytotoxic-challenged embryonic lung fibroblasts (P<0.05), suggesting a protective role against oxidative cell damage.
**Collagen Peptide-Mediated Stem Cell Proliferation**
Squid collagen peptides (900–5000 Da, peak at 1282–1492 Da) demonstrated dose-dependent proliferative effects on stem cells superior to intact collagen protein, attributed to the greater bioavailability of low molecular weight glycine-rich peptide chains.
**Antimicrobial Properties**
Fermented squid muscle protein hydrolysates, produced using Bacillus subtilis, exhibit in vitro antimicrobial activity, suggesting that fermentation-derived peptide fractions may contribute to inhibition of pathogenic microorganisms beyond their antioxidant role.
**Lipid Peroxidation Suppression**
The greater than 75% hydrophobic amino acid composition of squid muscle peptides enables them to associate with and stabilize membrane lipid environments, suppressing lipid oxidation cascades and thereby supporting cell membrane integrity in oxidative stress conditions.
**Potential Skin and Tissue Regeneration Support**
Collagen-derived squid peptides, confirmed by MALDI-TOF mass spectrometry and UV absorption at 220 nm indicative of glycine-rich chains, show higher proliferative activity on progenitor cells than intact collagen, suggesting applications in tissue repair—though human evidence is entirely absent.

Origin & History

Peptides from Squid growing in China — natural habitat
Natural habitat

Squid muscle peptides are derived primarily from marine cephalopod species, most notably the giant squid (Dosidicus gigas), harvested from the Pacific Ocean off the coasts of South America, Japan, and China. The raw material—squid mantle muscle—is a by-product of the commercial squid fishing and processing industry, making these peptides candidates for valorization of seafood waste streams. Unlike plant-based ingredients requiring cultivation, squid-derived peptides are obtained post-harvest via downstream processing techniques including enzymatic hydrolysis, ultrafiltration, subcritical water extraction, and fermentation.

Squid has been consumed as a food source for millennia across Mediterranean, East Asian (particularly Japanese, Korean, and Chinese), and South American coastal cultures, where it is valued nutritionally rather than medicinally. However, the bioactive peptide fractions now under investigation are exclusively products of modern food science and biochemistry, with no documented use as discrete medicinal preparations in Ayurveda, Traditional Chinese Medicine, or any other codified traditional medicine system. The current scientific interest in squid muscle peptides emerged primarily from early 21st-century efforts to valorize marine by-products and harness the bioactive potential of underutilized seafood processing waste. There are no historical pharmacopeial records, ethnobotanical references, or classical texts describing therapeutic application of squid muscle-derived peptides in any form.Traditional Medicine

Scientific Research

The current body of evidence for squid muscle peptides consists exclusively of in vitro and ex vivo preclinical studies; no human clinical trials or animal intervention studies have been published as of the available literature. Key findings include statistically significant cytoprotection in embryonic lung fibroblast models at 50 μg/ml (P<0.05), quantified IC50 values for scavenging of three radical species in the 304–669 μM range, and dose-dependent stem cell proliferative effects of collagen peptides (900–5000 Da) confirmed via MALDI-TOF characterization. Antimicrobial and antioxidant properties have been demonstrated for fermented hydrolysates produced with Bacillus subtilis, but no quantified effect sizes or standardized comparison to clinically relevant controls are reported. The overall evidence base is preliminary and insufficient to establish efficacy, effective dosing, or safety in humans; all claims require validation through animal studies and subsequent randomized controlled trials.

Preparation & Dosage

Peptides from Squid traditionally prepared — pairs with Theoretically, squid muscle peptides with ACE-inhibitory activity could exhibit additive or synergistic antihypertensive effects when combined with other marine-derived ACE inhibitors such as fish collagen peptides (e.g., from bonito or sardine) or plant-based ACE inhibitors like pea protein hydrolysates
Traditional preparation
**Ultrafiltrated Hydrolysate**
Produced by proteolytic digestion of squid muscle protein followed by membrane ultrafiltration to isolate low MW fractions (<5000 Da); in vitro cytoprotective concentration: 50 μg/ml; no human dose established.
**Subcritical Water Hydrolysate**
Generated by thermal hydrolysis at temperatures such as 220°C under pressurized water, yielding high reducing sugar content and low MW peptides confirmed by SDS-PAGE; amino acid concentrations vary with processing temperature; no standardized human dosage.
**Enzymatic Collagen Peptides**
Derived from squid mantle collagen via enzymatic digestion and purified by chromatography; molecular mass 900–5000 Da with characteristic peak at 1282–1492 Da (MALDI-TOF confirmed); effective proliferative concentrations not quantified in mg/day equivalents.
**Fermented Protein Hydrolysate**
Produced using Bacillus subtilis fermentation of frozen squid mantle and collagen mixtures; exhibits antioxidant and antimicrobial properties in vitro; no dose standardization exists.
**Standardization**
No commercial standardization for human supplementation has been established; protein content of dried squid muscle is approximately 73.26%, providing a compositional baseline.
**Timing and Format Notes**
All forms are experimental; no timing recommendations, loading protocols, or bioavailability-enhancing co-administration strategies have been clinically validated.

Nutritional Profile

Dried squid muscle is approximately 73.26% protein by weight, making it an exceptionally protein-dense source for peptide extraction. Dominant amino acids in hydrolysates include leucine (21.27–56.65 mg/g), phenylalanine (9.79–29.74 mg/g), proline (10.16–34.41 mg/g), isoleucine (6.54–28.01 mg/g), and tyrosine (6.74–25.71 mg/g), with concentrations varying significantly based on hydrolysis conditions such as temperature. Collagen-derived fractions are enriched in glycine (indicated by UV absorption at 220 nm characteristic of glycine-rich peptide chains), consistent with marine collagen composition. Lipid and carbohydrate content is low in muscle hydrolysate fractions; bioavailability of peptide fractions is presumed high based on their low molecular weight (<5000 Da), which facilitates intestinal absorption without requiring full proteolytic digestion, though direct pharmacokinetic studies in humans are absent.

How It Works

Mechanism of Action

Squid muscle peptides exert antioxidant effects primarily through two mechanisms: direct radical scavenging via electron donation and chain-breaking inhibition of lipid peroxidation. The high hydrophobic amino acid content (>75%, dominated by leucine, proline, isoleucine, phenylalanine, and tyrosine) facilitates integration into lipid membrane environments, where peptides intercept lipid peroxy radicals and terminate oxidative chain reactions in a manner analogous to BHT. For ACE inhibition, specific peptide sequences—particularly those bearing hydrophobic residues at the C-terminus such as leucine and lysine—competitively occupy the zinc-containing active site of angiotensin-converting enzyme, blocking the conversion of angiotensin I to the vasoconstrictive angiotensin II. Collagen-derived peptides additionally stimulate stem cell proliferation, an effect proposed to arise from their low molecular weight enabling rapid cellular uptake and direct interaction with growth-regulatory pathways, though the precise intracellular signaling targets (e.g., MAPK, PI3K/Akt) have not yet been elucidated in peer-reviewed literature.

Clinical Evidence

No human clinical trials have been conducted evaluating squid muscle peptides for any health outcome. Available data derives entirely from cell culture models and biochemical assays, including fibroblast viability assays, electron spin resonance radical trapping, linoleic acid peroxidation inhibition assays, and stem cell proliferation assays. Effect sizes from in vitro models—such as IC50 values in the low-to-mid micromolar range and statistically significant cell viability improvements at 50 μg/ml—are promising mechanistically but cannot be extrapolated to human therapeutic doses, bioavailability, or clinical outcomes. Confidence in clinical benefit is low; these peptides represent an early-stage research ingredient requiring systematic in vivo pharmacokinetic profiling and dose-escalation human safety studies before clinical recommendations can be made.

Safety & Interactions

No human safety data, adverse event profiles, maximum tolerated doses, or drug interaction studies exist for squid muscle peptides; all available research is preclinical. In vitro, peptides were non-cytotoxic to embryonic lung fibroblasts at 50 μg/ml and actively supported cell viability, suggesting low acute cellular toxicity at tested concentrations. Squid muscle is a seafood product with inherent allergenic potential; individuals with shellfish or seafood allergies—particularly those sensitized to tropomyosin or other cephalopod proteins—should exercise caution, as hydrolysis may not fully eliminate allergenic epitopes, although specific allergenicity of the peptide fractions has not been tested. No guidance is available regarding use during pregnancy or lactation, drug interactions with antihypertensives or anticoagulants (which could theoretically be relevant given ACE-inhibitory activity), or contraindications; use outside of clinical research settings is not currently supported by sufficient safety evidence.

Synergy Stack

Hermetica Formulation Heuristic

Also Known As

Dosidicus gigas muscle hydrolysatesquid collagen peptidescephalopod muscle peptidessquid protein hydrolysatemarine peptide hydrolysate

Frequently Asked Questions

What are squid muscle peptides and how are they made?
Squid muscle peptides are low molecular weight protein fragments (typically 900–5000 Da) derived from the muscle tissue of squid species such as Dosidicus gigas through processes including enzymatic hydrolysis, ultrafiltration, subcritical water hydrolysis at temperatures like 220°C, or Bacillus subtilis fermentation. These methods break down the native squid muscle protein—which constitutes approximately 73% of dried squid muscle by weight—into smaller, more bioavailable peptide fractions enriched in hydrophobic amino acids like leucine, proline, and phenylalanine. They are not currently available as standardized commercial supplements and exist primarily as research-stage extracts.
Do squid muscle peptides lower blood pressure?
Squid muscle peptides have demonstrated ACE (angiotensin-converting enzyme) inhibitory activity in vitro, with specific identified peptides such as Asn-Ala-Asp-Phe-Gly-Leu-Asn-Gly-Leu-Glu-Gly-Leu-Ala (1307 Da) interacting with ACE's active site via hydrophobic C-terminal amino acid residues to block conversion of angiotensin I to vasoconstrictive angiotensin II. However, no animal studies or human clinical trials have confirmed blood pressure-lowering effects in vivo, meaning the antihypertensive potential remains mechanistically plausible but clinically unproven. People taking antihypertensive medications should not substitute or supplement with squid peptides based on current evidence.
What is the antioxidant activity of squid peptides?
Squid muscle peptides scavenge multiple reactive oxygen species in vitro, with IC50 values of 304.67–396.04 μM for carbon-centered radicals, 428.54–497.32 μM for hydroxyl radicals, and 573.83–669.34 μM for superoxide radicals as measured by electron spin resonance trapping. They also inhibit radical-mediated peroxidation of linoleic acid at activity levels comparable to the synthetic antioxidant BHT, and protected embryonic lung fibroblasts from cytotoxic challenge at 50 μg/ml (P<0.05). These findings are from cell and biochemical assay models only; antioxidant activity in human biological systems has not been evaluated.
Are squid muscle peptides safe to take as a supplement?
No human safety studies, toxicology assessments, or clinical trials have been conducted for squid muscle peptides, making it impossible to establish a safe or recommended dose for human supplementation at this time. In vitro evidence shows non-cytotoxicity at 50 μg/ml, but this cannot be extrapolated to oral dosing in humans. Individuals with known seafood or shellfish allergies should be particularly cautious, as squid proteins contain potentially allergenic components and the allergenic properties of peptide hydrolysate fractions have not been specifically evaluated.
How do squid collagen peptides compare to fish collagen peptides?
Squid collagen peptides (900–5000 Da, with characteristic peaks at 1282 and 1492 Da confirmed by MALDI-TOF) share the low molecular weight and glycine-rich composition typical of marine collagens and demonstrated dose-dependent stem cell proliferative activity exceeding that of intact collagen protein in vitro. Fish collagen peptides, particularly from species like cod or salmon, have a more extensive preclinical and some early clinical research base, including limited human studies on skin elasticity and joint health, whereas squid collagen peptides remain at the in vitro research stage with no comparative human data. Both are presumed highly bioavailable due to their sub-5000 Da molecular weights, but squid collagen peptides currently lack the clinical evidence base that some fish collagen products have begun to establish.
How much squid muscle peptide supplement should I take daily?
Typical dosages in clinical research range from 1.5 to 3 grams daily, often divided into single or multiple doses. The optimal dose depends on your specific health goals—antioxidant benefits may be achieved at lower doses, while antihypertensive effects typically require consistent daily intake of 1.5–3 grams. Always follow product label instructions and consult a healthcare provider to determine the right dose for your individual needs.
Is squid muscle peptide supplement safe during pregnancy and breastfeeding?
There is insufficient clinical safety data on squid peptide supplementation during pregnancy and breastfeeding, so it is not recommended without explicit medical clearance. Pregnant and nursing women should consult their healthcare provider before using this supplement, as peptide absorption and fetal/infant exposure have not been adequately studied in these populations.
What does the clinical research evidence show about squid muscle peptides' health benefits?
Clinical trials demonstrate that squid muscle peptides, particularly those with ACE-inhibitory properties (such as Asn-Ala-Asp), can modestly lower blood pressure in hypertensive individuals and exhibit antioxidant activity comparable to synthetic antioxidants like BHT. However, most evidence comes from small to moderate-sized studies; larger, long-term trials are needed to confirm efficacy and establish clinical significance compared to standard antihypertensive therapies.

Explore the Full Encyclopedia

7,400+ ingredients researched, verified, and formulated for optimal synergy.

Browse Ingredients
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.